Holen Sie sich die Stockscreener-App
2.55
2.82%
0.07
Handel nachbörslich:
2.54
-0.010
-0.39%
Schlusskurs vom Vortag:
$2.48
Offen:
$2.44
24-Stunden-Volumen:
4.29M
Relative Volume:
1.17
Marktkapitalisierung:
$233.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.68M
KGV:
-1.5361
EPS:
-1.66
Netto-Cashflow:
$-54.24M
1W Leistung:
-29.36%
1M Leistung:
+9.91%
6M Leistung:
+119.83%
1J Leistung:
-44.32%
1-Tages-Spanne:
$2.30
$2.555
1-Wochen-Bereich:
$2.30
$3.575
52-Wochen-Spanne:
$0.9857
$5.46
Cabaletta Bio Inc Stock (CABA) Company Profile
Firmenname
Cabaletta Bio Inc
Sektor
Branche
Telefon
(267) 759-3100
Adresse
2929 ARCH STREET, PHILADELPHIA, PA
Vergleichen Sie CABA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
2.55 | 226.83M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Fortgesetzt | Jefferies | Buy |
| 2024-12-20 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | Eingeleitet | UBS | Buy |
| 2024-02-05 | Eingeleitet | Jefferies | Buy |
| 2023-11-29 | Eingeleitet | William Blair | Outperform |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Eingeleitet | Stifel | Buy |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-07-18 | Eingeleitet | Guggenheim | Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-06-30 | Eingeleitet | Mizuho | Buy |
| 2021-01-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-10-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Eingeleitet | Cowen | Outperform |
| 2019-11-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-19 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten
What technical signals suggest for Cabaletta Bio Inc. stock2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
Is Cabaletta Bio Inc. stock a contrarian buy2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Will Cabaletta Bio Inc. stock outperform Nasdaq indexSwing Trade & Free Risk Controlled Daily Trade Plans - newser.com
Cabaletta Bio Reports Breakthrough Results in Autoimmune Disease Trials - MyChesCo
How supply chain issues affect Cabaletta Bio Inc. stockQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
How Cabaletta Bio Inc. stock reacts to oil pricesPortfolio Gains Summary & Risk Adjusted Buy and Sell Alerts - fcp.pa.gov.br
Advanced analytics toolkit walkthrough for Cabaletta Bio Inc.Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
How Cabaletta Bio Inc. stock reacts to bond yields - newser.com
Will Cabaletta Bio Inc. see short term momentumMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Tools to assess Cabaletta Bio Inc.’s risk profile2025 Trade Ideas & Stock Portfolio Risk Management - newser.com
Can Cabaletta Bio Inc. stock resist sector downturnsBull Run & Consistent Return Investment Signals - fcp.pa.gov.br
How Cabaletta Bio Inc. stock compares to growth peersOptions Play & Safe Capital Growth Plans - fcp.pa.gov.br
Can Cabaletta Bio Inc. hit a new high this monthWeekly Risk Summary & Long-Term Capital Growth Ideas - newser.com
Why Cabaletta Bio Inc. stock could rally in 2025Analyst Upgrade & Weekly Return Optimization Plans - newser.com
Applying sector rotation models to Cabaletta Bio Inc.Quarterly Portfolio Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Cabaletta Bio (CABA): Assessing Valuation After Promising Clinical Trial Results and Growing Investor Interest - Yahoo Finance
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December - The Manila Times
Cabaletta Bio (Nasdaq: CABA) offers webcasts across Nov–Dec conferences; 30-day replays - Stock Titan
Is Cabaletta Bio Inc. stock attractive for long term wealth building2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Visualizing Cabaletta Bio Inc. stock with heatmapsMarket Activity Summary & Capital Protection Trade Alerts - newser.com
Top Biotech Stocks To Follow TodayNovember 1st - MarketBeat
Cabaletta Bio’s Remarkable Surge: Positive Clinical Data and Elevated Price Targets - StocksToTrade
Cabaletta Bio Stock Price Rises After Positive Clinical Data Announcement - timothysykes.com
Cabaletta Bio, Inc. (NASDAQ:CABA) Short Interest Update - MarketBeat
Jennison Associates LLC Boosts Holdings in Cabaletta Bio, Inc. $CABA - MarketBeat
Cabaletta Bio’s RESET-MS Study: A New Frontier in Multiple Sclerosis Treatment - MSN
Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock? - MSN
Can Cabaletta Bio Inc. stock maintain operating marginsEarnings Growth Summary & Safe Entry Trade Signal Reports - newser.com
Cabaletta Bio Stock Climbs Amid Positive Clinical Developments - StocksToTrade
Cabaletta Bio Poised for Growth Amid Positive Clinical Data Releases - timothysykes.com
Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $30.00 - MarketBeat
CABA Stock: Cantor Fitzgerald Raises Price Target to $30, Mainta - GuruFocus
Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):